S-101479

Ergogenic / SARM

Anabolic research positioning

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: SARM
Primary mechanism: Selective androgen receptor agonism
Primary market use: Muscle/bone research

Pharmacology

Molecular weight (Da): Not consistently disclosed
Oral bioavailability: Preclinical; oral data not established
Half-life: ~1–12 h provisional PK estimate
Route tags: Route-dependent / verify
Evidence level: Preclinical
Clinical status: Research
Value-for-money score: 2 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Sparse public data; include as research SARM only

Sources

https://pubchem.ncbi.nlm.nih.gov/#query=S-101479